Clover Health Investments (Clover Health Investments) Debt-to-Equity : 0.02 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments Debt-to-Equity?

Clover Health Investments's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2 Mil. Clover Health Investments's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3 Mil. Clover Health Investments's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $286 Mil. Clover Health Investments's debt to equity for the quarter that ended in Dec. 2023 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Clover Health Investments's Debt-to-Equity or its related term are showing as below:

CLOV' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.22 Med: 0.02 Max: 0.05
Current: 0.02

During the past 5 years, the highest Debt-to-Equity Ratio of Clover Health Investments was 0.05. The lowest was -0.22. And the median was 0.02.

CLOV's Debt-to-Equity is ranked better than
89.47% of 19 companies
in the Healthcare Plans industry
Industry Median: 0.4 vs CLOV: 0.02

Clover Health Investments Debt-to-Equity Historical Data

The historical data trend for Clover Health Investments's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments Debt-to-Equity Chart

Clover Health Investments Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-0.22

0.05

0.02

Clover Health Investments Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial												0.02	0.02	0.02	0.02	0.02

Competitive Comparison of Clover Health Investments's Debt-to-Equity

For the Healthcare Plans subindustry, Clover Health Investments's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clover Health Investments's Debt-to-Equity Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Debt-to-Equity falls into.

Clover Health Investments Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Clover Health Investments's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.665	+	2.998)	/	286.394
	=	0.02

Clover Health Investments's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.665	+	2.998)	/	286.394
	=	0.02

Clover Health Investments (NAS:CLOV) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Clover Health Investments Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Health Investments (Clover Health Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » Debt-to-Equity

Comparable Companies

BHG PFHO MRAI OSCR ALHC UNH ELV CI CVS HUM CNC MOH SZSE:000503 BSP:ODPV3 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

7QD:Germany

Address

3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067

Website

https://www.cloverhealth.com

Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.

Executives

Karen Soares	officer: General Counsel & Secretary	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy	director, officer: Chief Executive Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler	officer: Chief Financial Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest	officer: CEO of Home Care	C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp	officer: CEO of Value-Based Care	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin	officer: General Counsel	C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli	director, 10 percent owner, officer: Executive Chairperson	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton	director	C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso	officer: CEO of Medicare Advantage	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya	10 percent owner, other: See Remarks	THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025